ELAB
PMGC Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.83
+2.17%Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.61
- EPS estimate
- —
- Revenue actual
- $1.3M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | — | -$0.61 | — | $1.3M |
| May 14, 2026 | — | -$11 | — | $682.0K |
| Mar 26, 2026 | — | $3.98 | — | $304.1K |
| Nov 14, 2025 | — | -$20 | — | $285.9K |
| Aug 12, 2025 | — | -$1.61 | — | — |
| May 14, 2025 | — | -$10 | — | — |
| Nov 13, 2024 | — | -$343 | — | $527.5K |
| Aug 14, 2024 | — | -$392 | — | $605.5K |
| May 15, 2024 | — | -$392 | — | $614.6K |
| Mar 29, 2024 | — | -$392 | — | $698.6K |
| Dec 11, 2023 | — | -$0.08 | — | $554.7K |
| Jun 30, 2023 | — | -$3.76 | — | $316.5K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 14, 2026